Nasal Sprays
Selank 10mg Nasal Spray
A tuftsin-derived heptapeptide nasal spray studied for anxiolytic and nootropic effects without sedation.
Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring immune-regulating peptide, developed at Russia's Institute of Molecular Genetics beginning in the late 1970s. Following Phase 3 trials, it was registered in Russia in 2009 as a prescription anxiolytic for generalised anxiety disorder and neurasthenia, giving it a clinical trial and regulatory record most research peptides lack — though it remains unapproved by the FDA or any Western regulator. This pre-mixed nasal spray requires no reconstitution — simply prime and administer. Each bottle delivers 50 sprays at 200mcg per actuation, for a total content of 10mg.
Specifications
Research Benefits
- Registered anxiolytic in Russia — Approved there since 2009 for generalised anxiety disorder and neurasthenia following Phase 3 trials.
- Anxiolytic effects — Researched extensively for reducing anxiety without sedation or cognitive impairment.
- Nootropic properties — Demonstrates potential for enhancing memory, learning, and cognitive function.
- Immunomodulation — Derived from tuftsin, shows effects on immune system regulation and response.
- Neuroprotection — Investigated for protective effects on brain tissue and neuronal health.
- BDNF enhancement — Research suggests increased expression of brain-derived neurotrophic factor.
How It Works
Unlike benzodiazepines, Selank has been studied for producing anxiolytic effects without sedation, dependency, or withdrawal symptoms in research models — a distinguishing feature that has driven much of the research interest in this compound.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
